Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Certara Inc (NQ: CERT )

14.45 +0.41 (+2.92%)
Streaming Delayed Price Updated: 2:26 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,841
Open 14.05
Bid (Size) 14.42 (3)
Ask (Size) 14.44 (6)
Prev. Close 14.04
Today's Range 14.04 - 14.47
52wk Range 10.60 - 24.96
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines 
From Certara
Via GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire

Performance

YTD
-11.02%
-11.02%
1 Month
-9.23%
-9.23%
3 Month
-18.73%
-18.73%
6 Month
-39.44%
-39.44%
1 Year
+11.84%
+11.84%

More News

Read More
Certara Simcyp™ Group Awarded Two New Grants from US FDA
From Certara
Via GlobeNewswire
The Latest Analyst Ratings for Certara
Via Benzinga
Looking Into Certara's Return On Capital Employed
Via Benzinga
Analyst Expectations for Certara's Future
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
Via Benzinga
Expert Ratings for Certara
Via Benzinga
Where Certara Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Certara Reports Second Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
From Certara
Via GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
From Certara
Via GlobeNewswire
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
From Certara
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Via Benzinga
Are These 3 Small Momentum Stocks Setting Up Big Gains?
Via MarketBeat
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
A.I. Coming to Certara’s D360 Scientific Informatics Software
From Certara
Via GlobeNewswire
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
From Certara
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.